|
|
|
|
| Symbol(s): |
AZN |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
Astrazeneca PLC has a current Overall Rating of B (Positive). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Astrazeneca PLC has a current Overall Rating of B (Positive). Appreciation potential (91) is very high; Power Rating (48) is neutral. Relative to the S&P 500 Composite, Astrazeneca PLC -ADR has slightly more Growth than Value characteristics -- its appeal is likely to be to investors neutral towards Income. AZN is of the highest investment quality. Astrazeneca PLC's current technical position is mixed. Astrazeneca PLC's Power Rating is 48. However, the recent trend in AZN's earnings...
| | |
|
|
